Connect with us

Popular Penny Stocks to Buy in 2021? Here’s 4 You Should Know About

Why These 3 Penny Stocks Are Popular Among Traders Right Now
The post Popular Penny Stocks to Buy in 2021? Here’s 4 You Should Know About appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Published

on

4 Popular Penny Stocks to Watch in July 2021 

While finding the most popular penny stocks to watch can be a great strategy, there are a few other factors to consider. Depending on what type of investor you are, this includes where an industry or penny stock, in particular, may be headed in either the short or long term. 

Now, some of those who invest in penny stocks tend to do so for short-term gains. This happens to be the most popular strategy when it comes to trading penny stocks. However, others seek to find penny stocks that may have long-term potential, therefore pushing them out of penny stocks territory. 

[Read More] 4 Penny Stocks That Are Worth Adding to Your Watchlist in July

Regardless, it is extremely important to understand what type of trader you are and how to use that to your advantage. Considering that there is so much potential in the stock market right now, there are also hundreds of penny stocks to watch. So, with all of this in mind, here are four penny stocks to watch right now. 

4 Hot Penny Stocks to Watch Right Now 

  1. Cemtrex Inc. (NASDAQ: CETX
  2. Vinco Ventures Inc. (NASDAQ: BBIG
  3. Advaxis Inc. (NASDAQ: ADXS
  4. Tellurian Inc. (NASDAQ: TELL)

Cemtrex Inc. (NASDAQ: CETX)

With the tech industry growing every day, investors continue to look for the best tech stocks to watch right now. As a part of this sector, Cemtrex is a leader in areas such as IoT, artificial intelligence, computer vision, augmented reality, and virtual reality. Within these sectors, CETX produces a range of consumer products and engages in the manufacturing of digital applications, surveillance systems, and intelligent security. 

While Cemtrex did report a decrease in revenue in its most recent second-quarter report, the company attributes this to the pandemic. Covid has served to limit its operations, however, it still incurred roughly $5.9 million in operating expenses.

It’s worth noting that CETX did see an increase in its net income due to other income opportunities such as a settlement agreement and unrealized security gains. With CETX stock pushing around 11% in gains YTD, what do you think of its potential for July and beyond?

Vinco Ventures Inc. (NASDAQ: BBIG)

Another technology penny stock to consider right now is Vinco Ventures. We’ve been covering BBIG stock for quite some time due to its constant market momentum and the trending nature of its business. For some context, the company utilizes its B.I.G. strategy to further new opportunities and grow as a business.

[Read More] Best Penny Stocks To Buy This Week? 3 To Watch At The End Of July

BBIG’s business model is to first acquire another company where it then leverages internal traffic platforms to scale the business for the best chances of long-term growth. Recently BBIG announced the ‘spin out’ plans for Emmersive Entertainment to become its own standalone entity.

“This is a great opportunity for the shareholders of record on the effective date. The technology that Emmersive continues to develop is I believe industry-changing and we felt the best way to ensure the shareholders receive that value is by splitting the two entities and providing the shareholders the proverbial ‘two bites of the apple.’ We look forward to what Brian and the team can build and have full confidence in their ability to execute.”

CEO of Vinco Ventures, Christopher Ferguson

This is big news for the company and investors alike and could prove to be a profitable endeavor in the long term. While it may take some time to see the financial benefit of this announcement, in the meantime, is BBIG stock worth watching?

Penny_Stocks_to_Watch_Vinco

Advaxis Inc. (NASDAQ: ADXS)

In the past few months, the biotech industry has gained a great deal of traction. This is due to both the impact of the pandemic and the resulting focus on biotech stocks. And, Advaxis has benefitted greatly from both of these.

[Read More] 4 High Volume Penny Stocks to Watch in July 2021

This biopharmaceutical company focuses specifically on the clinical-stage development of its proprietary compounds. In greater depth, ADXS is working on immunotherapies based on live attenuated Listeria monocytogenes (Lm). These Lm-based antigen delivery products are bioengineered to secrete antigen fusion proteins. Additionally, these products are thought of as a novel technology in the field. Recently, Advaxis planned a merger with BioSight, an oncology company.

“After an extensive and thorough review of strategic and potentially transformative options for Advaxis, we are very pleased to announce a proposed merger with Biosight.

We believe the combined company’s strong and diversified oncology pipeline with late-stage and early-stage assets, near-term milestones, seasoned leadership team, and focus on both hematological malignancies and solid tumors have the potential to provide transformative benefits to patients while also providing value to our stockholders.” 

Kenneth A. Berlin, President, and CEO of Advaxis

While mergers can be quite common with biotech penny stocks, they are always exciting for both investors and the companies involved. And, this merger should help to promote both companies futures, as they work toward creating new compounds to help patients lives. Considering this, is ADXS stock worth adding to your list of penny stocks to watch?

Penny_Stocks_to_Watch_Advaxis

Tellurian Inc. (NASDAQ: TELL) 

Right now, the price of gas and other energy costs are rising. This increase is due to inflation and the higher demand for fossil fuels, energy penny stocks are performing well. As a major player in the U.S. liquefied natural gas industry, Tellurian, has a sizable role in the industry.

TELL also focuses on its merger and acquisition department, which has helped it to gain a sizable foothold in several unique areas of the energy industry. Additionally, its current development of its Driftwood LNG export plant in Louisiana, is one of the constant reasons that so many investors are showing interest in TELL stock.

Charif Souki, Executive Chairman of Tellurian Inc., states that the companies continued goal of M and A, is “a once in a lifetime opportunity” for producers to merge with or be acquired by TELL. On July 16th, Tellurian announced that it had canceled a deal with the French company, TotalEnergies SE, as it relates to the Driftwood LNG plant. It states that “The total agreements were terminated because they are not consistent with the commercial agreements that Driftwood…has reached with other counterparties.” 

In the past six months, shares of TELL stock have shot up by a solid 44% or so. And, in the past 12 months, that number jumps to over 264%. This is a sizable gain and one that should not be ignored by investors whatsoever. Considering the state of the energy sector now and in the future, will TELL be on your watchlist in July? 

Penny_Stocks_to_Watch_Tellurian

Are Popular Penny Stocks Worth Buying?

Finding the best penny stocks to buy is all about understanding how the markets move. While right now things are highly volatile, many expect an economic rebound in the near future.

[Read More] Small Cap Biotech Stocks Should Be On Your Watch List In 2021 & Here’s Why

Because of this, it is important to stay as up-to-date as possible with everything going on that could affect your penny stocks watchlist. But, with so much potential in the market, it can be easy to make a profit with penny stocks. Considering this, are popular penny stocks worth buying or not?

The post Popular Penny Stocks to Buy in 2021? Here’s 4 You Should Know About appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

Spread & Containment

Another major retailer cracks down on self-checkout at its stores

The value retailer is discouraging theft at its self-checkout counters by introducing more associate-assisted checkout transactions in its stores.

Published

on

Huge retail chains like Walmart  (WMT) , Target  (TGT) , CVS  (CVS) and others have faced a high amount of retail theft, or what they call inventory shrink, since 2020 and have been implementing measures to eliminate those costly losses.

Among the most common measures used by Walmart, Target and some others has been locking up popular items behind glass cases to prevent shoplifting. Customers shopping at these stores have encountered a lot of their favorite products, such as cosmetics, shampoo, over-the-counter drugs and even laundry detergent locked up in those cases.

Related: Target limits self-checkout, makes a change customers will love

Shoppers need to either push a button near the product to alert a worker to unlock the case or, in some situations, run around the store looking for a worker with the proper key to open the case. It's a very inconvenient problem for shoppers, and not all stores are consistent with their lockup policies.

For example, one Walmart store might lock up some of their instant coffee products, while another cross-town Walmart location, or even a Target competitor, doesn't lock up any coffee.

Retail stores have also implemented new self-checkout rules to discourage inventory shrink, but again, stores are inconsistent with their rules. Walmart stores have a 20 items or less rule for their self-checkout lanes to try to steer shoppers with more items to checkout clerks that might help reduce the occurrence of theft. But neither customers, nor workers seem to be observing that rule. Target on March 17 implemented a new 10 items or fewer rule in its self-checkout lanes, but we'll see if anyone enforces it.

These self-checkout requirements are also supposed to speed up the checkout process, but that only works if all the self-check registers are working and an adequate amount of checkout clerks are working registers as well.

The next step for retailers in addressing inventory shrink at self-checkout would be to eliminate self-check altogether.

Shopping in a Five Below store.

Pat Greenhouse/The Boston Globe via Getty Images

Five Below cuts back on self-checkout lanes 

After finishing the fourth quarter of 2023 with a "higher-than-planned shrink," or higher level of theft than expected in its stores, value retailer Five Below  (FIVE)  has implemented associate-assisted checkout in all of its stores for 2024, CEO Joel Anderson said on the company's earnings call on March 20.

"In addition, in our high-shrink stores, the primary option for checkout is more of the traditional, over-the-counter associate checkout," Anderson said. "We expect to have 75% of our transactions chain-wide assisted by an associate with a goal of 100% in our highest shrink, highest-risk stores to be fully transacted by an associate."

The retailer also checks receipts and adds guards

"Additionally, in those stores, we’re implementing further mitigation efforts, including receipt checking, additional store payroll and guards. We intend to measure progress as soon as Q2 when we perform a limited number of store counts," Anderson said.

Five Below tested several inventory shrink mitigation initiatives late in the third quarter and into the fourth quarter of 2023, which included product-related tests, front-end initiatives and guard programs, Anderson said in the earnings call. He said the most significant change the Philadelphia-based company made across most of the chain was to limit the number of self-checkout registers that were open, while positioning an associate upfront to further assist customers.

Anderson said he is confident the company's measures will help it over time, but the company has not included any financial impact for shrink reduction in its 2024 guidance. The company, however will aggressively pursue returning to pre-pandemic levels of shrink or offsetting the impact over the next few years, he said.

Read More

Continue Reading

Government

CCP-Linked Virologist Fired After Transferring Ebola From Winnipeg To Wuhan Resurfaces In China – And Is Collaborating With Military Scientists

CCP-Linked Virologist Fired After Transferring Ebola From Winnipeg To Wuhan Resurfaces In China – And Is Collaborating With Military Scientists

Published

on

CCP-Linked Virologist Fired After Transferring Ebola From Winnipeg To Wuhan Resurfaces In China - And Is Collaborating With Military Scientists

A virologist who had a "clandestine relationship" with Chinese agents and was subsequently fired by the Trudeau government has popped back up in China - where she's conducting research with Chinese military scientists and other virology researchers, including at the Wuhan Institute of Virology, where she's allegedly studying antibodies for coronavirus, as well as the deadly Ebola and Niaph viruses, the Globe and Mail reports.

Xiangguo Qiu and her husband Keding Cheng were fired from the National Microbiology Laboratory in Winnipeg, Canada and stripped of their security clearances in July of 2019.

Declassified documents tabled in the House of Commons on Feb. 28 show the couple had provided confidential scientific information to China and posed a credible security threat to the country, according to the Canadian Security Intelligence Service.

The Globe found that Dr. Qiu’s name appears on four Chinese patent filings since 2020, two with the Wuhan Institute of Virology whose work on bat coronaviruses has placed it at the centre of concerns that it played a role in the spread of COVID-19 – and two with the University of Science and Technology of China, or USTC. The patents relate to antibodies against Nipah virus and work related to nanobodies, including against coronaviruses. -Globe and Mail

Canadian authorities began questioning the pair's loyalty, as well as the potential for coercion or exploitation by a foreign entity, according to more than 600 pages of documents reported by The Counter Signal.

Highlights (via CTVNews.ca):

  • Qiu and Cheng were escorted out of Winnipeg's National Microbiology Laboratory in July 2019 and subsequently fired in January 2021.
  • The pair transferred deadly Ebola and Henipah viruses to China's Wuhan Institute of Virology in March 2019.
  • The Canadian Security Intelligence Service assessed that Qiu repeatedly lied about the extent of her work with institutions of the Chinese government and refused to admit involvement in various Chinese programs, even when evidence was presented to her.
  • [D]espite being given every opportunity in her interviews to describe her association with Chinese entities, "Ms. Qiu continued to make blanket denials, feign ignorance or tell outright lies."
  • A November 2020 Public Health Agency of Canada report on Qiu says investigators "weighed the adverse information and are in agreement with the CSIS assessment."
  • A Public Health Agency report on Cheng's activities says he allowed restricted visitors to work in laboratories unescorted and on at least two occasions did not prevent the unauthorized removal of laboratory materials.
  • Cheng was not forthcoming about his activities and collaborations with people from government agencies "of another country, namely members of the People's Republic of China."

Following their firings, Qiu returned to China despite it being under a pandemic travel lockdown until January, 2023.

"It’s very likely that she received quite preferential treatment in China on the basis that she’s proven herself. She’s done a very good job for the government of China," said Brendan Walker-Munro, senior research fellow at Australia’s University of Queensland Law School. "She’s promoted their interests abroad. She’s returned information that is credibly useful to China and to its ongoing research."

More via the Globe and Mail;

Documents reviewed by The Globe show that Dr. Qiu is most closely aligned with the University of Science and Technology of China (USTC) in Hefei. In March, 2023, a document posted by a Chinese pharmaceutical company listed Dr. Qiu as second amongst “major completion personnel” on a project awarded by the Chinese Preventive Medicine Association for study related to an anti-Ebola virus therapeutic antibody. Most of the other completion personnel were associated with the Chinese People’s Liberation Army.

USTC was founded by the Chinese Academy of Sciences and initially established to build up Chinese scientific expertise useful to the military, which at the time was pursuing technology to build satellites, intercontinental ballistic missiles and atomic bombs. The university has continued to maintain close military ties.

The document says Dr. Qiu works for USTC. Jin Tengchuan, the principal investigator at the Laboratory of Structural Immunology at USTC, lists her as a co-inventor on a patent. Mr. Jin did not respond to requests for comment.

A person who answered the phone at USTC told The Globe, “I don’t have any information about this teacher.”

In 2012, USTC signed a strategic co-operation agreement with the Army Engineering University of the People’s Liberation Army, designed to strengthen research on cutting-edge technology useful for communications, weaponry and other national-defence priorities.

Dr. Qiu is also listed as a 2019 doctoral supervisor for students studying virology at Hebei Medical University.

Well, that makes me wonder what circumstances she was under when she emigrated to Canada. Why did she come?” asked Earl Brown, a professor emeritus of biochemistry, microbiology and immunology at the University of Ottawa’s faculty of medicine who has worked extensively in China in the past. “People leave for more freedom from China, or to make more money. But China keeps tabs on most people so I am not sure if she came over to infiltrate or whether she came and the infiltration happened later through contact with China.”

It may be impossible to answer that question. Three former colleagues at the National Microbiolgy Lab have indicated that Dr. Qiu and her husband were diligent and pleasant to deal with, but largely kept to themselves outside of work. They say Dr. Qiu was a brilliant scientist with a strong work ethic, although her English was weak. The Globe is not identifying the three who did not want to be named.

Dr. Qiu is a medical doctor from Tianjin, China, who came to Canada for graduate studies in 1996. She started at the University of Manitoba, but began working at the national lab as a research scientist in 2006, working her way up to become head of the vaccine development and antiviral therapies section in the National Microbiology Laboratory’s special pathogens program.

She was also part of the team that helped develop ZMapp, a treatment for the deadly Ebola virus, which killed more than 11,000 people in West Africa between 2014 and 2016.

“My sense is this was part of a larger strategy by China to get access to our innovation system,” said Filippa Lentzos, an associate professor of science and international security at King’s College London. “It was a way for them to to find out what was going on in Canada’s premier lab.”

Initially trained as a medical doctor, Dr. Qiu graduated in 1985 from Hebei University in the coastal city of Tianjin, which lies southeast of Beijing. Dr. Qiu went on to obtain her master of science degree in immunology at Tianjin Medical University in 1990.

Her career at Canada’s top infectious disease lab in Winnipeg began in 2003, only four years after Ottawa opened this biosafety level 4 facility at the Canadian Science Centre for Human and Animal Health.

Over time, she built up a reputation for academic collaboration, particularly with China. It was welcomed by management who felt her work was helping build a name internationally for the National Microbiology Lab.

By the time Canadian officials intervened in 2018 and began investigating, documents show, Dr. Qiu was running 44 separate projects at the Winnipeg lab, an uncommonly large workload.

Her work with former colleague and microbiologist Gary Kobinger vaulted Dr. Qiu into the international spotlight. The pair developed a treatment for Ebola, one that in its first human application led to the full recovery of 27 patients with the infection during a 2014 outbreak in Liberia.

Mr. Kobinger’s career continued to soar and he is now director of the Galveston National Laboratory, a renowned biosafety level 4 facility in Texas. In 2022, he told The Globe that it was “heartbreaking” to see what had happened to his colleague. He declined to speak for this article.

“She had lost a lot of weight with all the stress. She was so convinced that this was all a misunderstanding … and she would go back to her job,” he said in 2022. “ Her career has been destroyed with all this. She was one of the top female Canadian scientists of virology and Canada has lost that.”

Over a period of 13 months, though, the Chinese-Canadian microbiologist and her biologist husband’s lives were turned upside down.

She went from being feted at Ottawa’s Rideau Hall with a Governor-General’s Award in May, 2018, to being locked out of the Winnipeg lab in July, 2019 – the high-security facility where she had made her name as a scientist in Canada. By January, 2021, she and Mr. Cheng were fired.

Last month, after being pressed into explaining what happened, the Canadian government finally disclosed the reasons for this extraordinary dismissal: CSIS found the pair had lied about and hid their co-operation with China from Ottawa.

A big question remains following their departure: Why would Dr. Qiu risk her career, including the stature associated with developing an Ebola treatment, for China?

Read the rest here...

Tyler Durden Thu, 03/21/2024 - 18:40

Read More

Continue Reading

International

You can now enter this country without a passport

Singapore has been on a larger push to speed up the flow of tourists with digital immigration clearance.

Published

on

In the fall of 2023, the city-state of Singapore announced that it was working on end-to-end biometrics that would allow travelers passing through its Changi Airport to check into flights, drop off bags and even leave and exit the country without a passport.

The latter is the most technologically advanced step of them all because not all countries issue passports with the same biometrics while immigration laws leave fewer room for mistakes about who enters the country.

Related: A country just went visa-free for visitors with any passport

That said, Singapore is one step closer to instituting passport-free travel by testing it at its land border with Malaysia. The two countries have two border checkpoints, Woodlands and Tuas, and as of March 20 those entering in Singapore by car are able to show a QR code that they generate through the government’s MyICA app instead of the passport.

A photograph captures Singapore's Tuas land border with Malaysia.

Here is who is now able to enter Singapore passport-free

The latter will be available to citizens of Singapore, permanent residents and tourists who have already entered the country once with their current passport. The government app pulls data from one's passport and shows the border officer the conditions of one's entry clearance already recorded in the system.

More Travel:

While not truly passport-free since tourists still need to link a valid passport to an online system, the move is the first step in Singapore's larger push to get rid of physical passports.

"The QR code initiative allows travellers to enjoy a faster and more convenient experience, with estimated time savings of around 20 seconds for cars with four travellers, to approximately one minute for cars with 10 travellers," Singapore's Immigration and Checkpoints Authority wrote in a press release announcing the new feature. "Overall waiting time can be reduced by more than 30% if most car travellers use QR code for clearance."

More countries are looking at passport-free travel but it will take years to implement

The land crossings between Singapore and Malaysia can get very busy — government numbers show that a new post-pandemic record of 495,000 people crossed Woodlands and Tuas on the weekend of March 8 (the day before Singapore's holiday weekend.)

Even once Singapore implements fully digital clearance at all of its crossings, the change will in no way affect immigration rules since it's only a way of transferring the status afforded by one's nationality into a digital system (those who need a visa to enter Singapore will still need to apply for one at a consulate before the trip.) More countries are in the process of moving toward similar systems but due to the varying availability of necessary technology and the types of passports issued by different countries, the prospect of agent-free crossings is still many years away.

In the U.S., Chicago's O'Hare International Airport was chosen to take part in a pilot program in which low-risk travelers with TSA PreCheck can check into their flight and pass security on domestic flights without showing ID. The UK has also been testing similar digital crossings for British and EU citizens but no similar push for international travelers is currently being planned in the U.S.

Read More

Continue Reading

Trending